CME Group Inc (CME) Position Lessened by Prospera Financial Services Inc

Prospera Financial Services Inc lessened its holdings in CME Group Inc (NASDAQ:CME) by 12.8% during the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 2,005 shares of the financial services provider’s stock after selling 295 shares during the period. Prospera Financial Services Inc’s holdings in CME Group were worth $345,000 as of its most recent SEC filing.

Several other hedge funds have also modified their holdings of CME. Edgewood Management LLC raised its position in CME Group by 2.8% during the second quarter. Edgewood Management LLC now owns 7,840,451 shares of the financial services provider’s stock valued at $1,285,207,000 after purchasing an additional 215,439 shares in the last quarter. Janus Henderson Group PLC raised its position in CME Group by 13.2% during the second quarter. Janus Henderson Group PLC now owns 6,129,157 shares of the financial services provider’s stock valued at $1,004,691,000 after purchasing an additional 716,655 shares in the last quarter. Fiera Capital Corp raised its position in CME Group by 2.8% during the second quarter. Fiera Capital Corp now owns 2,225,333 shares of the financial services provider’s stock valued at $364,777,000 after purchasing an additional 60,825 shares in the last quarter. Standard Life Aberdeen plc raised its position in CME Group by 38.1% during the second quarter. Standard Life Aberdeen plc now owns 1,765,929 shares of the financial services provider’s stock valued at $289,472,000 after purchasing an additional 487,442 shares in the last quarter. Finally, Vontobel Asset Management Inc. raised its position in CME Group by 14.3% during the second quarter. Vontobel Asset Management Inc. now owns 1,566,350 shares of the financial services provider’s stock valued at $263,940,000 after purchasing an additional 195,430 shares in the last quarter. Institutional investors own 84.29% of the company’s stock.

Shares of NASDAQ:CME opened at $178.64 on Monday. CME Group Inc has a 12-month low of $134.09 and a 12-month high of $183.79. The stock has a market cap of $60.65 billion, a PE ratio of 28.95, a P/E/G ratio of 3.37 and a beta of 0.64. The company has a current ratio of 1.09, a quick ratio of 1.08 and a debt-to-equity ratio of 0.15.



CME Group (NASDAQ:CME) last announced its quarterly earnings data on Thursday, October 25th. The financial services provider reported $1.45 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.42 by $0.03. CME Group had a return on equity of 9.18% and a net margin of 113.67%. The firm had revenue of $904.20 million for the quarter, compared to analysts’ expectations of $910.50 million. As a group, analysts anticipate that CME Group Inc will post 6.63 EPS for the current year.

A number of equities research analysts have weighed in on the company. Zacks Investment Research upgraded CME Group from a “sell” rating to a “hold” rating in a research report on Tuesday, September 18th. Compass Point initiated coverage on CME Group in a research note on Monday, July 9th. They set a “neutral” rating and a $170.00 price objective on the stock. BidaskClub cut CME Group from a “buy” rating to a “hold” rating in a research note on Tuesday, July 10th. Deutsche Bank reaffirmed a “buy” rating and set a $192.00 price objective (up from $185.00) on shares of CME Group in a research note on Thursday, October 11th. Finally, Wells Fargo & Co raised their price objective on CME Group from $175.00 to $177.00 and gave the company a “market perform” rating in a research note on Friday. Five research analysts have rated the stock with a hold rating, nine have issued a buy rating and one has given a strong buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and a consensus price target of $181.54.

In related news, Director Ronald A. Pankau sold 260 shares of the firm’s stock in a transaction dated Thursday, August 9th. The stock was sold at an average price of $163.17, for a total value of $42,424.20. Following the sale, the director now directly owns 3,900 shares of the company’s stock, valued at $636,363. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CAO Jack J. Tobin sold 7,820 shares of the firm’s stock in a transaction dated Wednesday, September 5th. The stock was sold at an average price of $174.87, for a total value of $1,367,483.40. Following the completion of the sale, the chief accounting officer now directly owns 17,534 shares in the company, valued at $3,066,170.58. The disclosure for this sale can be found here. Insiders have sold 29,188 shares of company stock worth $4,973,607 over the last ninety days. Insiders own 0.43% of the company’s stock.

CME Group Profile

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals.

Further Reading: S&P 500 Index

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply